DelveInsight’s “BK Virus Infection Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the BK Virus Infection, historical and forecasted epidemiology as well as the BK Virus Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The BK Virus Infection market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the BK Virus Infection market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; BK Virus Infection Market Insights
BK Virus Infection Overview
BK Virus (BKV) Infection also known as polyomavirus is a member of the human polyomavirus family. BKV resides dormant in uroepithelial cells as it is mostly acquired in childhood and is not known to cause tissue damage in immunocompetent individuals. The virus can become reactivated in case of immune deficiency (e.g., secondary to HIV infection or immunosuppressive medications), and result in cellular damage and organ dysfunction.
Some of the key facts of the BK Virus Infection Market Report:
- The BK Virus Infection market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
- The increase in number of transplants each year, routine screening after transplant, and approval of BK virus-specific treatments in the 7MM
- In 2021, the total 41,354 organ transplants were performed in the United States, an increase of 5.9 percent over 2020 and the first time the annual total exceeded 40,000, according to preliminary data from the Organ Procurement and Transplantation Network
- As per the study conducted by Bohl et al. titled “BK Virus Nephropathy and Kidney Transplantation,”the pre-transplantation seroprevalence was from 80-88% for BKV and 54-55% for JCV. The post transplantation rates of polyomavirus infection were 18-44% for BKV and 30-35% for JCV.
- Key BK Virus Infection Companies: AlloVir, Veru Therapeutics, Memo Therapeutics, AiCuris, and others
- Key BK Virus Infection Therapies: Posoleucel/ Viralym-M, MAU868, MTX-005, AIC468, and others
Get a Free sample for the BK Virus Infection Market Report –
https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-market
Key benefits of the BK Virus Infection Market report:
- BK Virus Infection market report covers a descriptive overview and comprehensive insight of the BK Virus Infection Epidemiology and BK Virus Infection market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The BK Virus Infection market report provides insights on the current and emerging therapies.
- BK Virus Infection market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The BK Virus Infection market report offers an edge that will help develop business strategies by understanding trends shaping and driving the BK Virus Infection market.
Download the report to understand which factors are driving BK Virus Infection epidemiology trends @ BK Virus Infection Epidemiological Insights
BK Virus Infection Market
The dynamics of the BK Virus Infection market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
BK Virus Infection Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
BK Virus Infection Epidemiology Segmentation:
The BK Virus Infection market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
- Total Prevalence of BK Virus Infection
- Prevalent Cases of BK Virus Infection by severity
- Gender-specific Prevalence of BK Virus Infection
- Diagnosed Cases of Episodic and Chronic BK Virus Infection
BK Virus Infection Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the BK Virus Infection market or expected to get launched during the study period. The analysis covers BK Virus Infection market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the BK Virus Infection Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Discover more about therapies set to grab major BK Virus Infection market share @ BK Virus Infection market forecast
BK Virus Infection Therapies and Key Companies
- Posoleucel/ Viralym-M: AlloVir
- MAU868: Veru Therapeutics
- MTX-005: Memo Therapeutics
- AiCuris: AIC468
BK Virus Infection Market Strengths
- Growing research and developmental activities about this indication
- In February 2021, Roche received first FDA clearance for urine sample type for BK virus quantitative test to aid in the improvement of care for transplant patients. This can significantly improve the diagnosis and thereby treatment rate of the indication.
Scope of the BK Virus Infection Market Report
- Study Period: 2019–2032
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key BK Virus Infection Companies: AlloVir, Veru Therapeutics, Memo Therapeutics, AiCuris, and others
- Key BK Virus Infection Therapies: Posoleucel/ Viralym-M, MAU868, MTX-005, AIC468, and others
- BK Virus Infection Therapeutic Assessment: BK Virus Infection current marketed and BK Virus Infection emerging therapies
- BK Virus Infection Market Dynamics: BK Virus Infection market drivers and BK Virus Infection market barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- BK Virus Infection Unmet Needs, KOL’s views, Analyst’s views, BK Virus Infection Market Access and Reimbursement
BK Virus Infection Market Barriers
- Several organizations are actively working to provide information and awareness of such rare and devastating disorder
- The current treatment options are very few for treating patients with BKV infection, which open a platform of new therapies to boost the market of BKV infection
Table of Contents
1. BK Virus Infection Market Report Introduction
2. Executive Summary for BK Virus Infection
3. SWOT analysis of BK Virus Infection
4. BK Virus Infection Patient Share (%) Overview at a Glance
5. BK Virus Infection Market Overview at a Glance
6. BK Virus Infection Disease Background and Overview
7. BK Virus Infection Epidemiology and Patient Population
8. Country-Specific Patient Population of BK Virus Infection
9. BK Virus Infection Current Treatment and Medical Practices
10. BK Virus Infection Unmet Needs
11. BK Virus Infection Emerging Therapies
12. BK Virus Infection Market Outlook
13. Country-Wise BK Virus Infection Market Analysis (2019–2032)
14. BK Virus Infection Market Access and Reimbursement of Therapies
15. BK Virus Infection Market Drivers
16. BK Virus Infection Market Barriers
17. BK Virus Infection Appendix
18. BK Virus Infection Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
To know more about BK Virus Infection treatment, visit @ BK Virus Infection Medications
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting